ProQR Therapeutics (PRQR) Change in Acquisitions & Divestments (2018 - 2019)

ProQR Therapeutics (PRQR) posted quarterly Change in Acquisitions & Divestments of -$14.1 million for Q2 2019, down 0.63% year-on-year from -$14.2 million in Q2 2018, and down 0.63% on a QoQ basis from -$14.0 million in Q2 2018.

ProQR Therapeutics (PRQR) Change in Acquisitions & Divestments (2018 - 2019) Analysis & Trends

ProQR Therapeutics (PRQR) has reported Change in Acquisitions & Divestments for 2 consecutive years, with -$14.1 million the latest figure, recorded in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 ProQR Therapeutics 185.44 Mn 93.15 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 -14.10 Mn
Jun 30, 2019 -14.10 Mn
Jun 30, 2018 -14.01 Mn
Jun 30, 2018 -14.01 Mn